Cargando…
Patient-derived tumor xenografts of lung squamous cell carcinoma alter long non-coding RNA profile but not responsiveness to cisplatin
Lung squamous cell carcinoma (LSCC), the second most common type of lung cancer, has received limited attention. Patient-derived tumor xenografts (PDTXs) are useful preclinical models to reproduce the diverse heterogeneity of cancer, but it is important to identify potential variations during their...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5950531/ https://www.ncbi.nlm.nih.gov/pubmed/29805594 http://dx.doi.org/10.3892/ol.2018.8401 |
_version_ | 1783322902656974848 |
---|---|
author | Lu, Dapeng Luo, Peng Zhang, Ju Ye, Yuanyuan Wang, Qi Li, Ming Zhou, Hangcheng Xie, Mingran Wang, Baolong |
author_facet | Lu, Dapeng Luo, Peng Zhang, Ju Ye, Yuanyuan Wang, Qi Li, Ming Zhou, Hangcheng Xie, Mingran Wang, Baolong |
author_sort | Lu, Dapeng |
collection | PubMed |
description | Lung squamous cell carcinoma (LSCC), the second most common type of lung cancer, has received limited attention. Patient-derived tumor xenografts (PDTXs) are useful preclinical models to reproduce the diverse heterogeneity of cancer, but it is important to identify potential variations during their establishment. A total of 18 PDTXs were established from 37 the surgical specimens and 16 were serially passaged to third generation. Second- and third-generation xenografts had a faster growth rate in mice. The tumor implantation success rate was associated with poorer differentiation, larger tumor volume and higher expression of Ki-67. The xenografts largely retained histological and key immunophenotypic features (including p53, p63, cytokeratin5/6, and E-cadherin). However, increased Ki-67 expression was identified in partial xenografts. Long non-coding RNA (lncRNA) and mRNA expression in third-generation xenografts differed from that of matched primary tumors. Gene Ontology and pathway analysis showed that mRNAs involved in cell cycle, and metabolism regulation were generally upregulated in xenografts, while those associated with immune responses were typically downregulated. Furthermore, the responses of xenografts to cisplatin were consistent with clinical outcome. In the present study, PDTXs of SCC were successfully established, and closely resembled their original tumor regarding their immunophenotype and response to cisplatin. Overall, PDTXS of LSCC altered the lncRNA profile and increased the proliferative activity of cancer cells, whilst retaining responsiveness to cisplatin. |
format | Online Article Text |
id | pubmed-5950531 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-59505312018-05-27 Patient-derived tumor xenografts of lung squamous cell carcinoma alter long non-coding RNA profile but not responsiveness to cisplatin Lu, Dapeng Luo, Peng Zhang, Ju Ye, Yuanyuan Wang, Qi Li, Ming Zhou, Hangcheng Xie, Mingran Wang, Baolong Oncol Lett Articles Lung squamous cell carcinoma (LSCC), the second most common type of lung cancer, has received limited attention. Patient-derived tumor xenografts (PDTXs) are useful preclinical models to reproduce the diverse heterogeneity of cancer, but it is important to identify potential variations during their establishment. A total of 18 PDTXs were established from 37 the surgical specimens and 16 were serially passaged to third generation. Second- and third-generation xenografts had a faster growth rate in mice. The tumor implantation success rate was associated with poorer differentiation, larger tumor volume and higher expression of Ki-67. The xenografts largely retained histological and key immunophenotypic features (including p53, p63, cytokeratin5/6, and E-cadherin). However, increased Ki-67 expression was identified in partial xenografts. Long non-coding RNA (lncRNA) and mRNA expression in third-generation xenografts differed from that of matched primary tumors. Gene Ontology and pathway analysis showed that mRNAs involved in cell cycle, and metabolism regulation were generally upregulated in xenografts, while those associated with immune responses were typically downregulated. Furthermore, the responses of xenografts to cisplatin were consistent with clinical outcome. In the present study, PDTXs of SCC were successfully established, and closely resembled their original tumor regarding their immunophenotype and response to cisplatin. Overall, PDTXS of LSCC altered the lncRNA profile and increased the proliferative activity of cancer cells, whilst retaining responsiveness to cisplatin. D.A. Spandidos 2018-06 2018-03-30 /pmc/articles/PMC5950531/ /pubmed/29805594 http://dx.doi.org/10.3892/ol.2018.8401 Text en Copyright: © Lu et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made. |
spellingShingle | Articles Lu, Dapeng Luo, Peng Zhang, Ju Ye, Yuanyuan Wang, Qi Li, Ming Zhou, Hangcheng Xie, Mingran Wang, Baolong Patient-derived tumor xenografts of lung squamous cell carcinoma alter long non-coding RNA profile but not responsiveness to cisplatin |
title | Patient-derived tumor xenografts of lung squamous cell carcinoma alter long non-coding RNA profile but not responsiveness to cisplatin |
title_full | Patient-derived tumor xenografts of lung squamous cell carcinoma alter long non-coding RNA profile but not responsiveness to cisplatin |
title_fullStr | Patient-derived tumor xenografts of lung squamous cell carcinoma alter long non-coding RNA profile but not responsiveness to cisplatin |
title_full_unstemmed | Patient-derived tumor xenografts of lung squamous cell carcinoma alter long non-coding RNA profile but not responsiveness to cisplatin |
title_short | Patient-derived tumor xenografts of lung squamous cell carcinoma alter long non-coding RNA profile but not responsiveness to cisplatin |
title_sort | patient-derived tumor xenografts of lung squamous cell carcinoma alter long non-coding rna profile but not responsiveness to cisplatin |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5950531/ https://www.ncbi.nlm.nih.gov/pubmed/29805594 http://dx.doi.org/10.3892/ol.2018.8401 |
work_keys_str_mv | AT ludapeng patientderivedtumorxenograftsoflungsquamouscellcarcinomaalterlongnoncodingrnaprofilebutnotresponsivenesstocisplatin AT luopeng patientderivedtumorxenograftsoflungsquamouscellcarcinomaalterlongnoncodingrnaprofilebutnotresponsivenesstocisplatin AT zhangju patientderivedtumorxenograftsoflungsquamouscellcarcinomaalterlongnoncodingrnaprofilebutnotresponsivenesstocisplatin AT yeyuanyuan patientderivedtumorxenograftsoflungsquamouscellcarcinomaalterlongnoncodingrnaprofilebutnotresponsivenesstocisplatin AT wangqi patientderivedtumorxenograftsoflungsquamouscellcarcinomaalterlongnoncodingrnaprofilebutnotresponsivenesstocisplatin AT liming patientderivedtumorxenograftsoflungsquamouscellcarcinomaalterlongnoncodingrnaprofilebutnotresponsivenesstocisplatin AT zhouhangcheng patientderivedtumorxenograftsoflungsquamouscellcarcinomaalterlongnoncodingrnaprofilebutnotresponsivenesstocisplatin AT xiemingran patientderivedtumorxenograftsoflungsquamouscellcarcinomaalterlongnoncodingrnaprofilebutnotresponsivenesstocisplatin AT wangbaolong patientderivedtumorxenograftsoflungsquamouscellcarcinomaalterlongnoncodingrnaprofilebutnotresponsivenesstocisplatin |